DSC_6767
Wednesday, May 13, 2026
31.7
C
Bengaluru
Hot topics
DigiStorm 2018: Intent, Content, Strategy and Skills
The pharma industry in India is entering a very interesting variant of the post-digital marketing era. The term “post-digital marketing” is used to depict a state where the lines between physical and digital blur considerably for a customer. However, in the context of pharma, this means a state where the industry has stopped questioning the need for digital and has begun to implement very interesting digital marketing initiatives.
Semaglutide: Just Another Off-Patent Generic? Or a Different Beast Entirely?
As over 50 generic versions of the blockbuster weight-loss...
Key Challenges Facing Indian Pharma
With the Second Wave hitting India, customers (patients and physicians) will continue to socially distance themselves in the foreseeable future. Pharma must use the field force for reach and relationship and digital for frequency and personalised content for better customer experience.
The pandemic has made doctors adopt Telehealth in a substantial way to shore up their revenues and this will continue to be one of their channels to engage patients. Telehealth along with EMR/EHR, digital therapeutics and wearables is enabling doctors to better care for their patients. There are many ways in which pharma can support the digital evolution of doctors.
Can Eli Lilly Outrun the Same-Glutide Stampede with Tirzepatide and Orforglipron?
The "aspirinization" of obesity—moving from a niche, high-cost injectable...
Incentives in Healthcare: The Quiet Force Shaping Outcomes
In 2017, economist Richard Thaler won the Nobel Prize...
Do Retail Pharmacies Really Care about Patients?
The chemist shop—jammed between a chai stall and a...
Indian Oncology: An Unasked Question, the Challenges Ahead
A Brief History of Scale and an Unasked Question
In...
Are Quick Remedies Keeping Patients Away from Doctors?
The recent Mint Lounge analysis captured a striking consumer...
From Tragedy to Trust: What the CDCSO Can Learn from Dr. Frances Oldham Kelsey
Abstract
The U.S. Food and Drug Administration (FDA) evolved from...
Biocon’s Landmark Succession Planning: Claire Mazumdar is the Future Leader
In a landmark decision for India’s biotechnology sector, Kiran...
Do Retail Pharmacies Really Care about Patients?
The chemist shop—jammed between a chai stall and a...
Indian Oncology: An Unasked Question, the Challenges Ahead
A Brief History of Scale and an Unasked Question
In...
Are Quick Remedies Keeping Patients Away from Doctors?
The recent Mint Lounge analysis captured a striking consumer...
From Tragedy to Trust: What the CDCSO Can Learn from Dr. Frances Oldham Kelsey
Abstract
The U.S. Food and Drug Administration (FDA) evolved from...
Biocon’s Landmark Succession Planning: Claire Mazumdar is the Future Leader
In a landmark decision for India’s biotechnology sector, Kiran...
Do Retail Pharmacies Really Care about Patients?
The chemist shop—jammed between a chai stall and a...
Indian Oncology: An Unasked Question, the Challenges Ahead
A Brief History of Scale and an Unasked Question
In...
Are Quick Remedies Keeping Patients Away from Doctors?
The recent Mint Lounge analysis captured a striking consumer...
From Tragedy to Trust: What the CDCSO Can Learn from Dr. Frances Oldham Kelsey
Abstract
The U.S. Food and Drug Administration (FDA) evolved from...
Biocon’s Landmark Succession Planning: Claire Mazumdar is the Future Leader
In a landmark decision for India’s biotechnology sector, Kiran...
Do Retail Pharmacies Really Care about Patients?
The chemist shop—jammed between a chai stall and a...
Indian Oncology: An Unasked Question, the Challenges Ahead
A Brief History of Scale and an Unasked Question
In...
Are Quick Remedies Keeping Patients Away from Doctors?
The recent Mint Lounge analysis captured a striking consumer...
From Tragedy to Trust: What the CDCSO Can Learn from Dr. Frances Oldham Kelsey
Abstract
The U.S. Food and Drug Administration (FDA) evolved from...
Biocon’s Landmark Succession Planning: Claire Mazumdar is the Future Leader
In a landmark decision for India’s biotechnology sector, Kiran...
Hot topics
Healthcare Disruption – Will Ola, Swiggy, Pharmaeasy, and Hospitals Converge to Deliver Health Care on Call at Your Doorstep?
How long before digital Unicorns like Ola, Swiggy, Pharmeasy, and many others realize the humongous opportunity of delivering health care at the doorstep?
Imagine an app like Ola, where instead of entering where you want to go, you enter the nature of your medical need/emergency and search and find a range of hospitals/doctors/paramedics who can act as the first responders and reach your home in an ambulance or a motorbike with an HCP as a pillion rider with all necessary equipment from the thermometer to defibrillator depending on the nature of the medical care needed and triage and route you/your loved ones to the nearest hospital with an indicative cost of treatment in partnership with health insurance companies?
Novo Nordisk’s Big Reset: What 9,000 Job Cuts Signal for Pharma’s Future
For years, Novo Nordisk was the poster child of growth. Its GLP-1 drugs, Ozempic and Wegovy, didn’t just change obesity treatment — they reshaped the company’s balance sheet. Demand outpaced supply, public awareness skyrocketed, and Novo’s market cap surged.
But growth always attracts challengers. Enter Eli Lilly with Mounjaro and Zepbound, and a wave of competitors and compounded generics threatening margins. Add in slowing sales growth and operational bloat from years of expansion, and suddenly Novo’s leadership had to answer tough questions about sustainability.
Healthcare Isn’t Working As Well As It Should – A Brief Summary Of The ZS Report 2024
The ZS report discusses how people feel about healthcare...
Time for Pharma to Re-think its Way of Working
https://www.youtube.com/watch?v=BOO_CNxEzwQ
Too many Medical Reps are chasing too few doctors,...
Worldclass Healthcare But Out of Reach for Most Indians?
When an eminent cardiologist like Dr. Sunil Chandy—former Director...
Do Retail Pharmacies Really Care about Patients?
The chemist shop—jammed between a chai stall and a...
Indian Oncology: An Unasked Question, the Challenges Ahead
A Brief History of Scale and an Unasked Question
In...
Are Quick Remedies Keeping Patients Away from Doctors?
The recent Mint Lounge analysis captured a striking consumer...
From Tragedy to Trust: What the CDCSO Can Learn from Dr. Frances Oldham Kelsey
Abstract
The U.S. Food and Drug Administration (FDA) evolved from...
Biocon’s Landmark Succession Planning: Claire Mazumdar is the Future Leader
In a landmark decision for India’s biotechnology sector, Kiran...
Do Retail Pharmacies Really Care about Patients?
The chemist shop—jammed between a chai stall and a...
Indian Oncology: An Unasked Question, the Challenges Ahead
A Brief History of Scale and an Unasked Question
In...
Are Quick Remedies Keeping Patients Away from Doctors?
The recent Mint Lounge analysis captured a striking consumer...
From Tragedy to Trust: What the CDCSO Can Learn from Dr. Frances Oldham Kelsey
Abstract
The U.S. Food and Drug Administration (FDA) evolved from...
Biocon’s Landmark Succession Planning: Claire Mazumdar is the Future Leader
In a landmark decision for India’s biotechnology sector, Kiran...
Do Retail Pharmacies Really Care about Patients?
The chemist shop—jammed between a chai stall and a...
Indian Oncology: An Unasked Question, the Challenges Ahead
A Brief History of Scale and an Unasked Question
In...
Are Quick Remedies Keeping Patients Away from Doctors?
The recent Mint Lounge analysis captured a striking consumer...
From Tragedy to Trust: What the CDCSO Can Learn from Dr. Frances Oldham Kelsey
Abstract
The U.S. Food and Drug Administration (FDA) evolved from...
Biocon’s Landmark Succession Planning: Claire Mazumdar is the Future Leader
In a landmark decision for India’s biotechnology sector, Kiran...
Do Retail Pharmacies Really Care about Patients?
The chemist shop—jammed between a chai stall and a...
Indian Oncology: An Unasked Question, the Challenges Ahead
A Brief History of Scale and an Unasked Question
In...
Are Quick Remedies Keeping Patients Away from Doctors?
The recent Mint Lounge analysis captured a striking consumer...
From Tragedy to Trust: What the CDCSO Can Learn from Dr. Frances Oldham Kelsey
Abstract
The U.S. Food and Drug Administration (FDA) evolved from...
Biocon’s Landmark Succession Planning: Claire Mazumdar is the Future Leader
In a landmark decision for India’s biotechnology sector, Kiran...
MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More
Headlines
Do Retail Pharmacies Really Care about Patients?
The chemist shop—jammed between a chai stall and a...
Indian Oncology: An Unasked Question, the Challenges Ahead
A Brief History of Scale and an Unasked Question
In...
Are Quick Remedies Keeping Patients Away from Doctors?
The recent Mint Lounge analysis captured a striking consumer...
From Tragedy to Trust: What the CDCSO Can Learn from Dr. Frances Oldham Kelsey
Abstract
The U.S. Food and Drug Administration (FDA) evolved from...
Newsletter
Get important news delivered directly to your inbox and stay connected!